Novartis AG officer Victor Bulto Carulla filed a Form 144 notice on October 28, 2026, proposing the sale of 6,000 American Depositary Shares through Fidelity Brokerage Services LLC on the New York Stock Exchange.

Key Highlights

  • Proposed sale: 6,000 American Depositary Shares (ADS) with an aggregate market value of $933,180.00, according to the filing.
  • Seller: Victor Bulto Carulla, identified in the filing as an officer of Novartis AG.
  • Exchange and broker: The sale is proposed on the NYSE, to be executed through Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917.
  • Shares outstanding: The filing reports 1,908,151,679 ADS units outstanding at the time of notice.
  • Source of shares: The shares were acquired through five separate restricted stock vestings from the issuer, dated between January 20, 2024, and January 29, 2026, all classified as compensation.
  • No sales in prior three months: The filing reports nothing to report for securities sold during the past three months.

Novartis Officer Proposes ADS Sale Sourced from Multiple Restricted Stock Vestings

According to the Form 144 notice filed with the SEC on October 28, 2026, Victor Bulto Carulla, an officer of Novartis AG (NYSE:NVS), has proposed the sale of 6,000 American Depositary Shares with an aggregate market value of $933,180.00. The approximate date of sale is listed as October 28, 2026. The filing was submitted through Fidelity Brokerage Services LLC, acting as broker for the transaction.

The filing details five acquisition transactions underlying the shares to be sold. Bulto Carulla received 61 ADS on January 20, 2024; 326 ADS on January 25, 2024; 638 ADS on January 25, 2025; 209 ADS on January 26, 2025; and 4,766 ADS on January 29, 2026. All five acquisitions are described as restricted stock vestings from the issuer, with the nature of payment listed as compensation in each instance. None of the acquisitions were identified as gifts.

The filing was signed by Wade Moss as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Victor Bulto Carulla. The notice also states that the seller "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed," as required under the Form 144 attestation language.

What Was Disclosed

Novartis AG officer Victor Bulto Carulla filed a Rule 144 notice to sell 6,000 ADS valued at $933,180.00, acquired through five restricted stock vestings between January 2024 and January 2026, with no reported sales in the prior three months.